In a roundup review of scientific studies recently published, a study out of RCSI University of Medicine and Health Sciences and the HSE Health Protection Surveillance Centre (HPSC) in Ireland further defined the association between comorbidities and poor outcomes with Covid-19.

Countries across the globe shut their borders to Britain on Dec. 21 due to fears about a highly infectious new coronavirus strain, causing travel chaos and raising the prospect of food shortages days before Britain is set to leave the European Union.

Global coronavirus cases rose by more than 400,000 for the first time, a record one-day increase as much of Europe enacts new restrictions to curb the outbreak.

Political polarization and online misinformation are threatening vaccination programs worldwide, with public trust volatile and varying widely between countries, according to a global vaccine confidence study.

The United Kingdom’s COVID-19 death toll exceeds 40,000, by far the worst yet reported in Europe, raising more questions about Prime Minister Boris Johnson’s handling of the coronavirus crisis.

All of the world’s top 10 pharmaceutical companies have established substantial operations in Ireland and from 2003 to today, there has been dynamic growth of biologics manufacturing in Ireland, according to IDA Ireland.

Opioid use has reached crisis proportions not only in the United States but also in Canada and some European countries, as prescription opioid painkillers have become much more common, the OECD club of wealthy nations said.

Ireland’s tax authorities have demanded that drugmaker Perrigo – formerly known as Elan – pay 1.64 billion euros ($1.9 billion) in taxes relating to the calendar-year 2013, a U.S. securities filing showed.

Ireland is the latest candidate to lure the European Medicines Agency should the EMA uproot from London after Britain’s vote to leave the European Union.

McKesson Announces Agreement to Purchase the Pharmaceutical Distribution Division of UDG Healthcare plc • McKesson to acquire the pharmaceutical distribution division of UDG Healthcare plc for €408 million in cash. • Acquisition will add a leader in pharmaceutical distribution across the Republic of Ireland and Northern Ireland to McKesson’s European business. • The acquisition is […]